Avacta Group PLC (LON:AVCT)

Avacta Group PLC (LON:AVCT)

Share Price
26.75 p
0 (0.00 %)
Market Cap
£31.07 m
Proactive Investors - Run By Investors For Investors

Avacta Group PLC

At Avacta we have developed Affimer technology, an engineered alternative to antibodies. Based on a small protein, Affimer technology can be quickly developed to bind with high specificity and affinity to a wide range of targets.

Affimer proteins can be developed as therapeutic molecules and can be used in a wide range of other life sciences applications in research and diagnostics.

Market: AIM:AVCT
52-week High/Low: 51.000p / 21.000p
Sector: Pharma & Biotech
Market Cap: £31.07 m
Website: www.avacta.com
col 3
col 4
col 5
col 6

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use